BeOne Medicines Ltd.
BeOne Medicines Ltd. (ONC) Revenue
Annual & quarterly revenue history · segment & region breakdown
ONC · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBeOne Medicines Ltd. trailing twelve-month (TTM) revenue is $5.74B, an increase of 40.23% year-over-year from $5.34B in FY2025.
Revenue trend
2025 – 2013 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $5.34B | +$1.53B | +40.23% |
| 2024-12-31 | $3.81B | +$1.35B | +54.96% |
| 2023-12-31 | $2.46B | +$1.04B | +73.65% |
| 2022-12-31 | $1.42B | +$0.24B | +20.37% |
| 2021-12-31 | $1.18B | +$0.87B | +280.83% |
| 2020-12-31 | $0.31B | -$0.12B | -27.87% |
| 2019-12-31 | $0.43B | +$0.23B | +116.03% |
| 2018-12-31 | $0.20B | -$0.04B | -16.85% |
| 2017-12-31 | $0.24B | +$0.24B | +22179.16% |
| 2016-12-31 | $0.00B | -$0.01B | -87.86% |
Compare revenue vs peers
Medical - PharmaceuticalsCompare ONC revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BeOne Medicines Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BeOne Medicines Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from BeOne Medicines Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ONC revenue · 5 questionsONC's trailing twelve-month (TTM) revenue is $5.74B. That is an increase of 40.23% year-over-year from $5.34B in FY2025.
▸ Source: FMP · BeOne Medicines Ltd. SEC filings · GAAP · BeOne Medicines Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026